Healthcare & Pharmaceuticals

Excellent results shown in breakthrough cancer treatment

Christophe Martin Brawand A breakthrough procedure that employs the body’s immune response has shown excellent results in clinical trials, for the treatment of advanced forms of blood cancer. The trials were conducted at the Fred Hutchinson Cancer Research Center in Seattle. The procedure employs a form of genetic engineering, to reprogram T-cells to eliminate tumours.…

Read More

3D-Printed organs anyone?

Josh Moss According to Engadget, a technology news outlet, doctors at the Wake Forest Institute for Regenerative Medicine announced yesterday that they have managed to 3D print “living” tissue and organs that functioned properly when implanted in animals. The new printer developed over the past decade is called the Integrated Tissue and Organ Printing System…

Read More

Breaking down an outbreak

Anupurba Roy The world has barely recovered from Ebola, and yet there is already a new global health scare on the block. The mosquito-borne Zika virus, which has been around since 1947 but has only gained prominence in the last few months for the way it has ‘explosively’ spread through South America. The otherwise relatively…

Read More

The debates on proton beam therapy

Josh Moss You may have heard of Proton Beam Therapy when reading about how Ashya King’s parents were temporarily arrested in 2014 for smuggling their son out of the UK, who was suffering from a brain tumour. This was so that he could receive Proton Beam Therapy in Prague. Such actions were illegal, as they…

Read More

BIOCON

Raph Amsili In 2014, showing $460bn revenues, Biocon is the largest pharmaceutical company in India. The CEO is the famous Madam Kiran Mazumdar-Shaw, considered to be the wealthiest entrepreneur in biotechnologies. After her degree in zoology at the University of Ballarat in Australia, Kiran joined Biocon, an Irish company looking for a young entrepreneur capable…

Read More

New ovarian cancer treatment available to patients in the UK

Christophe Brawand A medicine effective in treating ovarian, fallopian tube and peritoneal cancer has been approved by health officials, and will now be available to patients in the UK. Olaparib will be made available to women who have BRCA1 or BRCA2 mutations of cancer, and who have already gone through three courses of chemotherapy. Ovarian…

Read More

Painful Painkillers

Josh Moss Reckitt Benckiser is in the public spotlight after deceiving its customers about the packaging for Nurofen, a drug that relieves pain. According to the ACCC (The Australian Competition and Consumer Commission), the British pharmaceutical firm, Reckitt Benckiser (also known as RB), has made misleading representations on the packaging of each Nurofen Specific Pain…

Read More

Perrigo acquires Retin-A from Matawan Pharmaceuticals

Christophe Brawand Irish pharmaceutical company Perrigo is acquiring a portfolio of generic forms of Retin-A from Matawan Pharmaceuticals LLC, a subsidiary of generics producer, Rouses Point Pharmaceuticals. The deal was concluded for an undisclosed amount, but will be finalised in Q1 2016, and will be adding more than $0.20 in Perrigo’s adjusted EPS within the…

Read More